Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-10-11
2010-10-12
Bausch, Sarae (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100
Reexamination Certificate
active
07811765
ABSTRACT:
The present invention provides methods and compositions for detecting a predisposition to an inflammation-mediated cardiovascular disease in a human subject by detecting a level of leukotriene C4 synthase (LTC4S) gene product in a sample from a human subject indicative of a predisposition to an inflammation-mediated cardiovascular disease or detecting the presence or absence of an allele of LTC4S indicative of a predisposition to an inflammation-mediated cardiovascular disease. In addition, the present invention also provides kits for practicing the methods.
REFERENCES:
patent: 6316196 (2001-11-01), Morten
patent: 6576753 (2003-06-01), Lam et al.
patent: 6939674 (2005-09-01), Anderson et al.
patent: 2003/0224418 (2003-12-01), Braun et al.
patent: 2004/0209288 (2004-10-01), Mehrabian et al.
patent: 2005/0113408 (2005-05-01), Helgadottir et al.
patent: 2006/0019269 (2006-01-01), Helgadottir et al.
Back et al. (Arterioscler. Thromb. Vasc. Biol., 2008, vol. 28, pp. 805-806).
Hattersley et al. (Lancet, 2005, vol. 366, pp. 1315-1323).
Ionnidis (Plost Med, 2005, 2(8):e124).
Kroese et al. (Genetics in Medicine, vol. 6 (2004), p. 475-480).
LTC4S Gene, Leukotriene C4 Synthase, Genecard, pp. 1-12, printed Dec. 21, 2008, available at www.genecards.org.
Dwyer, J.,et al. Arachidonate 5-lipoxygenase promoter genotype, dietary archidonic acid, and atherosclerosis. New England Journal of Medicine. 2004, vol. 350, pp. 29-37.
Helgadottir, A., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genetics. 2004, vol. 36, No. 3, pp. 233-239.
Helgadottir, A., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet. 2005, vol. 76, pp. 505-509.
Helgadottir, A., et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nature Genetics. 2006, vol. 38, No. 1, pp. 68-74.
Mehrabian, M., et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circulation Research. 2002, vol. 91, pp. 120-126.
Mehrabian, M., et al. Response to arachidonate 5-lipoxygenase variants in atherosclerosis, obesity, and bone trials. Circulation Research. 2006, vol. 98, pp. e68.
Iovannisci David M.
Lammer Edward J.
Bausch Sarae
Bozicevic Field & Francis LLP
Chandra Shweta
Children's Hospital & Research Center at Oakland
LandOfFree
Methods and compositions for determining predisposition to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for determining predisposition to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for determining predisposition to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195421